Qlucore AB (publ) (NOVKAN) - Net Assets

Latest as of December 2025: Skr15.06 Million SEK ≈ $1.62 Million USD

Based on the latest financial reports, Qlucore AB (publ) (NOVKAN) has net assets worth Skr15.06 Million SEK (≈ $1.62 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr16.73 Million ≈ $1.80 Million USD) and total liabilities (Skr1.67 Million ≈ $179.61K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Qlucore AB (publ) liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr15.06 Million
% of Total Assets	90.03%
Annual Growth Rate	2.08%
5-Year Change	-87.71%
10-Year Change	-74.69%
Growth Volatility	116.47

Qlucore AB (publ) - Net Assets Trend (2010–2025)

This chart illustrates how Qlucore AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Qlucore AB (publ) for the complete picture of this company's asset base.

Annual Net Assets for Qlucore AB (publ) (2010–2025)

The table below shows the annual net assets of Qlucore AB (publ) from 2010 to 2025. For live valuation and market cap data, see NOVKAN market cap overview.

Year	Net Assets	Change
2025-12-31	Skr15.06 Million ≈ $1.62 Million	-75.82%
2024-12-31	Skr62.30 Million ≈ $6.70 Million	+30.70%
2023-12-31	Skr47.66 Million ≈ $5.13 Million	-55.42%
2022-12-31	Skr106.91 Million ≈ $11.51 Million	-12.75%
2021-12-31	Skr122.54 Million ≈ $13.19 Million	+69.52%
2020-12-31	Skr72.28 Million ≈ $7.78 Million	+314.97%
2019-12-31	Skr17.42 Million ≈ $1.87 Million	-47.78%
2018-12-31	Skr33.36 Million ≈ $3.59 Million	-13.83%
2017-12-31	Skr38.71 Million ≈ $4.17 Million	-34.97%
2016-12-31	Skr59.52 Million ≈ $6.41 Million	+171.49%
2015-12-31	Skr21.93 Million ≈ $2.36 Million	-19.66%
2014-12-31	Skr27.29 Million ≈ $2.94 Million	+43.96%
2013-12-31	Skr18.96 Million ≈ $2.04 Million	+244.72%
2012-12-31	Skr5.50 Million ≈ $591.78K	-78.77%
2011-12-31	Skr25.90 Million ≈ $2.79 Million	+134.01%
2010-12-31	Skr11.07 Million ≈ $1.19 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Qlucore AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 45553500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr11.78 Million	78.18%
Other Components	Skr458.82 Million	3045.62%
Total Equity	Skr15.06 Million	100.00%

Qlucore AB (publ) Competitors by Market Cap

The table below lists competitors of Qlucore AB (publ) ranked by their market capitalization.

Company	Market Cap
Sadot Group Inc. NASDAQ:SDOT	$326.20K
LogicMark Inc NASDAQ:LGMK	$327.18K
Elixxer Ltd V:ELXR	$328.10K
Rajvir Industries Limited NSE:RAJVIR	$330.50K
AdCapital AG F:ADC	$325.98K
Dewhurst plc LSE:DWHA	$323.07K
Eden Research plc LSE:EDEN	$322.56K
Mitra Komunikasi Nusantara Tbk PT JK:MKNT	$322.28K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Qlucore AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 62,300,000 to 15,065,000, a change of -47,235,000 (-75.8%).
Net loss of 46,771,000 reduced equity.
Other factors decreased equity by 464,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-46.77 Million	-310.46%
Other Changes	Skr-464.00K	-3.08%
Total Change	Skr-	-75.82%

Book Value vs Market Value Analysis

This analysis compares Qlucore AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.20x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.01x to 0.20x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	Skr4.16	Skr0.03	x
2011-12-31	Skr8.89	Skr0.03	x
2012-12-31	Skr1.52	Skr0.03	x
2013-12-31	Skr3.69	Skr0.03	x
2014-12-31	Skr2.10	Skr0.03	x
2015-12-31	Skr1.50	Skr0.03	x
2016-12-31	Skr3.68	Skr0.03	x
2017-12-31	Skr2.13	Skr0.03	x
2018-12-31	Skr1.53	Skr0.03	x
2019-12-31	Skr0.68	Skr0.03	x
2020-12-31	Skr1.64	Skr0.03	x
2021-12-31	Skr1.83	Skr0.03	x
2022-12-31	Skr1.80	Skr0.03	x
2023-12-31	Skr0.60	Skr0.03	x
2024-12-31	Skr0.54	Skr0.03	x
2025-12-31	Skr0.12	Skr0.03	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Qlucore AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -310.46%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.11x
Recent ROE (-310.46%) is below the historical average (-132.49%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	-64.57%	0.00%	0.00x	1.27x	Skr-8.25 Million
2011	-71.07%	-260.43%	0.18x	1.53x	Skr-21.00 Million
2012	-608.98%	-872.31%	0.21x	3.40x	Skr-34.04 Million
2013	-39.13%	-409.16%	0.07x	1.35x	Skr-9.31 Million
2014	-58.55%	-3399.79%	0.01x	1.33x	Skr-18.71 Million
2015	-89.45%	-6954.61%	0.01x	1.25x	Skr-21.80 Million
2016	-37.48%	-7242.86%	0.00x	1.23x	Skr-28.26 Million
2017	-145.17%	-49732.74%	0.00x	1.32x	Skr-60.07 Million
2018	-137.71%	-12831.01%	0.01x	1.37x	Skr-49.27 Million
2019	-207.22%	-1122.36%	0.07x	2.55x	Skr-37.84 Million
2020	-56.03%	-45000.00%	0.00x	1.15x	Skr-47.73 Million
2021	-37.28%	-2681.10%	0.01x	1.09x	Skr-57.94 Million
2022	-49.09%	-6969.99%	0.01x	1.13x	Skr-63.18 Million
2023	-136.14%	-6269.47%	0.02x	1.38x	Skr-69.66 Million
2024	-71.53%	-318328.57%	0.00x	1.07x	Skr-50.80 Million
2025	-310.46%	0.00%	0.00x	1.11x	Skr-48.28 Million

Industry Comparison

This section compares Qlucore AB (publ)'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $75,073,976
Average return on equity (ROE) among peers: -30.42%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Qlucore AB (publ) (NOVKAN)	Skr15.06 Million	-64.57%	0.11x	$326.04K
Aardvark Therapeutics, Inc. Common Stock (AARD)	$-27.92 Million	0.00%	0.00x	$93.41 Million
Abcellera Biologics Inc (ABCL)	$10.25 Million	-21.57%	1.29x	$1.40 Billion
Abeona Therapeutics Inc (ABEO)	$3.60 Million	-91.89%	0.28x	$302.62 Million
Acumen Pharmaceuticals Inc (ABOS)	$188.78 Million	-22.70%	0.04x	$169.73 Million
Abpro Holdings, Inc. (ABP)	$-85.14 Million	0.00%	0.00x	$2.00 Million
Absci Corp (ABSI)	$176.18 Million	-62.76%	0.23x	$771.73 Million
Arbutus Biopharma Corp (ABUS)	$-18.49 Million	0.00%	0.00x	$854.72 Million
ABVC Biopharma Inc (ABVC)	$-2.01 Million	0.00%	0.00x	$27.18 Million
Abivax SA American Depositary Shares (ABVX)	$196.01 Million	-75.37%	0.67x	$9.51 Billion
ACADIA Pharmaceuticals Inc (ACAD)	$309.49 Million	-29.88%	0.05x	$3.59 Billion

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#30885 Global

#6075 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23